---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-058173"
form_type: "8-K"
ticker: "STAA"
cik: "0000718937"
company_name: "STAAR SURGICAL CO"
filed_at: "2025-04-24T23:59:59+00:00"
generated_at: "2026-05-23T07:31:08.874882+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# STAAR Surgical board reshuffles; Silverman rejoins, Weisner exits, Jiang takes APAC strategy role with $1.275M RSUs

## Summary
- Louis Silverman reappointed to board effective April 24, 2025; board expands to 7 members.
- Director Aimee Weisner will not stand for re-election at June 2025 annual meeting; board to shrink to 6.
- Wei Jiang becomes Chief of APAC Strategy under consulting agreement through fiscal 2025, receiving RSUs valued at $1.275M.
- CEO cites China distribution challenges, pre-tariff inventory at distributors, consignment agreements, and Swiss production ramp-up.
- Company emphasizes cost control and improving profitability; earnings call expected in May 2025.

## SEC filing metadata
- accession: 0000950170-25-058173
- form_type: 8-K
- ticker: STAA
- cik: 0000718937
- company_name: STAAR SURGICAL CO
- filed_at: 2025-04-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/718937/000095017025058173/0000950170-25-058173-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/718937/000095017025058173/staa-20250424.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-058173
- JSON: https://secwatch.observer/filing/0000950170-25-058173.json
- Plain text: https://secwatch.observer/filing/0000950170-25-058173.txt

## Key facts
- Executive change
  Aimee S. Weisner departed as director at STAAR SURGICAL CO.
  - Action: not stand for re-election
  - Role: director
  source text: Ms. Weisner notified the Company that she has chosen not to stand for re-election when her term expires at the 2025 Annual Meeting
  evidence_url: https://www.sec.gov/Archives/edgar/data/718937/000095017025058173/0000950170-25-058173-index.htm
- Executive change
  Wei Jiang was appointed as Chief of APAC Strategy at STAAR SURGICAL CO.
  - Action: appointed
  - Role: Chief of APAC Strategy
  source text: the Company entered into a consulting agreement with Mr. Jiang to serve as a special strategic advisor to the Company’s Asia Pacific business through the end of fiscal 2025, in the temporary role of Chief of APAC Strategy
  evidence_url: https://www.sec.gov/Archives/edgar/data/718937/000095017025058173/0000950170-25-058173-index.htm
- Executive change
  Louis E. Silverman was appointed as director at STAAR SURGICAL CO.
  - Action: appointed
  - Role: director
  source text: the Board appointed Louis E. Silverman, who served on the Company’s Board from 2014-2022, as a director, effective April 24, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/718937/000095017025058173/0000950170-25-058173-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.